Las Vegas, NV -- (SBWIRE) -- 10/31/2012 -- Beststocksdaily is one of leading U.S. stock update providers to valued investors. Following are the notable volume movers as reported by http://beststocksdaily.com/
Yamana Gold Inc. (USA) (NYSE:AUY) stock increased 7.01% to $19.99 after the company reported third-quarter net earnings of $59.97 million or $0.08 per share, as compared to $115.77 million or $0.16 per share in the year ago quarter. Adjusted earnings were $178 million or $0.24 earnings per share in the third quarter of 2012, compared to $190 million or $0.26 per share in the same quarter of 2011. Revenues for the quarter were $611.81 million compared to $555.21 million in the same quarter of 2011. Analysts expected the company to report earnings of $0.23 per share on consensus revenue estimate of $613.89 million for the quarter.
To Get complete technical analysis on AUY go to http://beststocksdaily.com/p2/index.php?company=AUY
Loral Space & Communications Ltd. (NASDAQ:LORL) stock gained 6.50% to $78.02 after the company announced that it was selected by the U.S. Air Force Space and Missile Systems Center (SMC) to develop affordable design concepts for next generation Protected Military Satellite Communications (MILSATCOM).
Can LORL Continue to Jump? Find Out Here http://beststocksdaily.com/p2/index.php?company=LORL
Quanta Services Inc (NYSE:PWR) stock increased 9.41% to $25.83 after the company reported third-quarter net income of $96.4 million or $0.45 per share, from $52.0 million or $0.25 per share in the same quarter last year. Analysts expected the company to report earnings of $0.36 per share for the quarter. Adjusted earnings per share were $0.48 for the third quarter of 2012. Revenues in the third quarter of 2012 were $1.69 billion, as compared to revenues of $1.25 billion in the third quarter of 2011. Analysts had consensus revenue estimate of $1.65 billion for the quarter.
Get Free Trend Analysis on PWR Here http://beststocksdaily.com/p2/index.php?company=PWR
Entropic Communications, Inc. (NASDAQ:ENTR) stock increased 5.20% to $4.76 after the company reported third quarter net revenues of $89.8 million, an increase of 8%, as compared with $83.1 million in the second quarter of 2012. The Company's third quarter GAAP net income was $0.4 million, or $0.00 per share (diluted), as compared to GAAP net income of $0.2 million, or $0.00 per share (diluted) in the second quarter of 2012.
Additionally, equities researchers at Benchmark Co. dropped their target price on shares of ENTR from $7.50 to $7.00 in a report issued last week. The firm currently has a “buy” rating on the stock.
Can ENTR Continue to Jump? Find Out Here http://beststocksdaily.com/p2/index.php?company=ENTR
Hemispherx BioPharma, Inc (NYSE:HEB) stock gained 4.62% to $0.680. The company recently announced that the U.S. Food and Drug Administration ("FDA") has scheduled for December 20, 2012 a meeting of the Arthritis Advisory Committee ("AAC") to discuss the Ampligen® New Drug Application for Chronic Fatigue Syndrome ("CFS") which is currently under review by the FDA. As previously announced, the Prescription Drug User Fee Act ("PDUFA") review goal for the FDA to complete its review is February 2, 2013.
To Get complete technical analysis on HEB go to http://beststocksdaily.com/p2/index.php?company=HEB
Beststocksdaily’s team is engaged in providing valuable and updated news information on U.S. stocks on a regular basis. Beststocksdaily’s instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. To Get Instant updates in the inbox, readers are advised to sign up for free at Beststocksdaily.com.
The assembled information disseminated by beststocksdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. beststocksdaily.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)